Abstract
With the efficacy of gene therapy verified in phase III trials, cancer patients will consider whether to accept gene therapy sooner or later. The purpose of this study is to investigate the attitudes of oncology physicians and nurses regarding effective gene therapy. A questionnaire was administered to 368 oncology physicians and nurses. A total of 328 valid questionnaires were returned (response rate, 89.1%). Gene therapy was considered as very safe or safe by 256 (78.0%) participants. Regardless of the stage of cancer, participants who advised patients to enroll in clinical trials and considered gene therapy as safe tended to accept the effective gene therapy. Gene therapy is considered to be a safe treatment. Most participants are willing to accept effective and verified gene therapy on the assumption that they themselves suffer from cancers.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brower V (2008) Cancer gene therapy steadily advances. J Natl Cancer Inst 17,100(18):1276–1278
Schapowal AG, Baer HU (2002) Medical ethics in peace and in the armed conflict. Mil Med 167(8 Suppl):26–31
Dettweiler U, Simon P (2001) Points to consider for ethics committees in human gene therapy trials. Bioethics 15(5–6):491–500
Wilson JM (2009) Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency. Mol Genet Metab 96(4):151–157
Gottweis H (2002) Gene therapy and the public: a matter of trust. Gene Ther 9(11):667–669
Abbott A (2001) Genetic medicine gets real. Nature 411(6836):410–412
Xie Y, Zhang H, Sheng W, Xiang J, Ye Z, Yang J (2008) Adenovirus-mediated ING4 expression suppresses lung carcinoma cell growth via induction of cell cycle alteration and apoptosis and inhibition of tumor invasion and angiogenesis. Cancer Lett 271(1):105–116
Ning T, Yan X, Lu ZJ et al (2008) Gene therapy in orthotopic lung cancer murine model with angiogenesis inhibitor, endostatin. Hum Gene Ther 20(2):103–111
Gordon EM, Levy JP, Reed RA, Petchpud WN, Liu L, Wendler CB, Hall FL (2008) Targeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ. Int J Oncol 33(4):665–675
Du XB, Lang JY, Xu JR et al (2008) Vesicular stomatitis virus matrix protein gene enhances the antitumor effects of radiation via induction of apoptosis. Apoptosis 13(10):1205–1214
Gao ZN, Wei YQ, Yang PS, Xu X, Zhao HQ, Huan X, Kang B (2007) Combined effects of soluble vascular endothelial growth factor receptor FLT-1 gene therapy and cisplatin chemotherapy in human tongue carcinoma xenografts. Oral Oncol 43(5):477–483
Senzer N, Nemunaitis J (2009) A review of contusugene ladenovec (Advexin) p53 therapy. Curr Opin Mol Ther 11(1):54–61
Bonatti J, Haeusler C, Klaus A, Fink M, Hammerer-Lercher A, Laufer G (2002) Acceptance of gene therapy by the heart surgery patient. Eur J Cardio-thorac surg 21(6):981–986
Holm S, Jayson G (2001) What do patients, their relatives and medical staff know about genetic therapy? Bull Med Ethics 173:13–19
Guinn BA, Mulherkar R (2008) International progress in cancer gene therapy. Cancer Gene Ther 15(12):765–775
Macer DR (1992) Public acceptance of human gene therapy and perceptions of human genetic manipulation. Hum Gene Ther 3(5):511–518
Macer DR, Akiyama S, Alora AT et al (1995) International perceptions and approval of gene therapy. Hum Gene Ther 6(6):791–803
Hedman M, Muona K, Hedman A et al (2009) Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer. Gene Ther 16(5):629–634
Li JY, Liu C, Zou LQ, Huang MJ, Yu CH, You GY, Jiang YD, Li H, Jiang Y (2008) To tell or not to tell: attitudes of Chinese oncology nurses towards truth telling of cancer diagnosis. J Clin Nurs 17(18):2463–2470
Jiang Y, Li JY, Liu C, Huang MJ, Zhou L, Li M, Zhao X, Wei YQ (2006) Different attitudes of oncology clinicians toward truth telling of different stages of cancer. Support Care Cancer 14(11):1119–1125
Jiang Y, Liu C, Li JY et al (2007) Different attitudes of Chinese patients and their families toward truth telling of different stages of cancer. Psychooncology 16(10):928–936
Chen Z, Gu K, Zheng Y, Zheng W, Lu W, Shu XO (2008) The use of complementary and alternative medicine among Chinese women with breast cancer. J Altern Complement Med 14(8):1049–1055
Cui Y, Shu XO, Gao Y, Wen W, Ruan ZX, Jin F, Zheng W (2004) Use of complementary and alternative medicine by chinese women with breast cancer. Breast Cancer Res Treat 85(3):263–270
Joffe S, Weeks JC (2002) Views of American oncologists about the purposes of clinical trials. J Natl Cancer Inst 94(24):1847–1853
Slevin ML, Stubbs L, Plant HJ, Wilson P, Gregory WM, Armes PJ, Downer SM (1990) Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. Br Med J 300(6737):1458–1460
Acknowledgement
We thank all the persons who help us in this study.
Conflict of Interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Zi-ming Liu and Chang Liu contributed equally to this work.
Rights and permissions
About this article
Cite this article
Liu, Zm., Liu, C., Li, Jy. et al. The Attitude of Oncology Physicians and Nurses to the Acceptance of New Drugs for Gene Therapy. J Canc Educ 26, 248–253 (2011). https://doi.org/10.1007/s13187-010-0172-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13187-010-0172-0